Most CD36 DNA methylation data derive from genome-wide studies focused on metabolic diseases such as obesity [237], and only one study focused on cancer reported the correlation of CD36 DNA hypermethylation with progression in lung tumours [238]. This evidence concerns the gene CD36 and obesity due to melanocortin 4 receptor deficiency.